Bio-Techne Corporation (TECH)

Nasdaq · Healthcare · Biotechnology
$72.67-0.04%As of 2026-11-22 · USD
Last session low $72.66Last session high $72.77
52-week low $43.2052-week high $72.88
Market cap
$11.42B
Sector
Healthcare
P/E (TTM)
66.7x
Dividend yield
0.44%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)53.0In the neutral range (30 to 70)
MACD (12, 26, 9)0.05Below its signal line (0.07); histogram -0.02
Bollinger %B (20, 2)29%Inside the bands (72.59 to 72.87)
SMA 2072.73Price is 0.1% below
SMA 5072.58Price is 0.1% above
SMA 20063.52Price is 14.4% above
ATR (20)0.21% of priceAverage true range per day
52-week position99%In the upper part of the 43.20 to 72.88 range

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.

Latest fiscal yearEnded 2026-06-30: revenue of $1.22B and an operating margin of 22.4%.

More in Biotechnology